Medical device manufacturers are under increasing pressure to bring products to global markets faster while maintaining strict regulatory compliance. Under the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), organizations must provide accurate, understandable information in the languages required by each target market. At the same time, the volume of content requiring translation continues to grow: from Instructions for Use (IFUs) and labeling to software interfaces, training materials, and post-market surveillance documentation. As a result, many manufacturers are exploring AI translation for medical devices to accelerate multilingual content delivery and reduce costs.
But can AI translation be used for medical devices without compromising compliance, patient safety, or market access?
The answer is yes, but only when AI translation for medical devices is implemented within a robust quality and regulatory framework. In highly regulated industries such as medical devices, AI should be viewed as an efficiency tool rather than a replacement for expert human review.
In this article, we’ll examine the opportunities and risks of AI translation for medical devices, explain what MDR, IVDR, and the EU AI Act mean for manufacturers, and outline best practices for building a compliant translation strategy.
Table of Contents
Why Medical Device Translation Is a Regulatory Requirement
Medical device users, including healthcare professionals, caregivers, laboratory personnel, and patients, depend on accurate information to use products safely and effectively. A mistranslated warning, dosage instruction, operating procedure, or safety notice can lead to misuse, adverse events, regulatory findings, or product recalls.
This is why MDR and IVDR require manufacturers to provide information in languages determined by the member states where devices are marketed. Labels, Instructions for Use, software content, and other user-facing documentation must be clear, accurate, and understandable for their intended audience.
Ultimately, manufacturers remain responsible for the quality of translated content regardless of the tools or providers used to produce it.
How AI Is Transforming Medical Device Translation
Artificial intelligence has made significant advances in language technology over the past decade. Modern AI translation systems can process large volumes of content quickly and deliver increasingly accurate results, particularly when trained on specialized terminology and supported by translation memories.
For medical device companies, AI offers several compelling advantages:
- Faster translation of large documentation sets
- Greater consistency across product portfolios
- Improved reuse of previously translated content
- Reduced turnaround times for document updates
- More efficient management of multilingual product launches
- Better scalability when entering new markets
These benefits are especially valuable in environments where content changes frequently due to design updates, regulatory requirements, or post-market activities. AI can help organizations manage growing translation demands more efficiently while supporting faster global expansion. However, speed alone does not guarantee compliance.
The Biggest Risks of Using AI Translation for Medical Devices
While AI translation technology continues to improve, medical device content presents unique challenges that require careful oversight.
Terminology Inconsistencies
Medical devices rely on precise technical and clinical terminology. Even minor inconsistencies can create confusion among users, healthcare professionals, or regulatory reviewers. A device component, clinical concept, or safety feature translated differently across documents may undermine clarity and increase risk.
Regulatory Language Errors
Regulatory documentation often contains highly specific wording that must align with established standards and expectations. AI systems may generate translations that sound natural while failing to preserve the regulatory intent of the source text. Such errors may not be immediately obvious but can create compliance concerns during audits or regulatory submissions.
Context and Nuance Failures
Medical and technical language is highly contextual. AI models can occasionally misinterpret abbreviations, specialized terminology, or product-specific concepts, particularly when sufficient context is not available. These errors may be subtle but can significantly affect meaning.
Labeling and IFU Risks
Instructions for Use and product labeling represent some of the highest-risk content categories in medical devices. An incorrectly translated warning, contraindication, or operating instruction can affect patient safety and expose manufacturers to regulatory and legal consequences. For this reason, raw AI output should never be considered publication-ready for regulated medical device documentation.
Is AI Translation for Medical Devices Allowed Under MDR and IVDR?
One of the most common questions manufacturers ask is whether AI translation is permitted under MDR and IVDR. The regulations themselves do not prohibit the use of AI translation tools. Instead, MDR and IVDR focus on outcomes. Manufacturers must ensure that translated information is accurate, understandable, appropriate for the intended user, and capable of supporting safe device use.
Organizations remain accountable for translation quality regardless of whether content is translated by humans, AI systems, or a combination of both. This means translation workflows should include documented quality controls, review procedures, terminology management, and validation processes.
What the EU AI Act Means for Medical Device Translation
The European Union’s AI Act introduces a new regulatory framework for the development and use of artificial intelligence systems. While the implications will vary depending on the specific AI tools and use cases involved, manufacturers should expect greater emphasis on transparency, governance, accountability, and risk management when implementing AI-enabled workflows. For translation processes, this means organizations should consider:
- How AI systems are selected and validated
- Whether human oversight is built into workflows
- How translation quality is measured and documented
- How terminology and regulatory language are controlled
- How AI-generated outputs are reviewed before publication
As regulatory expectations evolve, companies that establish clear governance around AI use will be better positioned to demonstrate compliance and manage risk. The focus is increasingly shifting from simply adopting AI to implementing AI responsibly.
The Compliance-Ready Model: AI Plus Human Life Sciences Experts
The most successful medical device translation strategies do not rely exclusively on AI or exclusively on manual processes. Instead, they combine the efficiency of AI with the expertise of qualified life sciences professionals.
AI for Efficiency
AI translation for medical devices can provide significant value in areas such as:
- First-pass translation
- Content reuse
- Translation memory leverage
- Terminology suggestions
- Workflow automation
- Large-scale multilingual updates
These capabilities can reduce project timelines and improve consistency across documentation sets.
Human Experts for Compliance
Human specialists remain essential for:
- Medical and technical review
- Regulatory language validation
- Terminology management
- Cultural and linguistic adaptation
- In-country review support
- Quality assurance activities
Experienced life sciences linguists understand not only language but also the regulatory and clinical context in which content will be used.
Validation and Traceability
A compliant workflow should also include:
- Documented review procedures
- Quality assurance checkpoints
- Terminology governance
- Version control
- Audit-ready records
- Risk-based validation processes
This hybrid approach delivers the efficiency benefits of AI while maintaining the quality standards required for regulated environments.
What to Look for in a Medical Device Translation Partner
As AI becomes more widely adopted, choosing the right translation partner is more important than ever. Medical device manufacturers should look for providers with:
- Deep Life Sciences Expertise: Translators and reviewers should understand medical device terminology, clinical concepts, and regulatory requirements.
- MDR and IVDR Knowledge: Translation workflows should align with the realities of regulatory submissions, labeling requirements, and market-specific obligations.
- AI Governance Processes: Providers should be able to explain how AI is used, how outputs are reviewed, and how quality is controlled.
- Accessibility and Usability Expertise: Translation quality is not only about linguistic accuracy. Information must also be accessible, understandable, and usable by intended audiences.
- Robust Quality Management Systems: Documented procedures, quality controls, and traceability mechanisms are essential in regulated industries.
- Global Regulatory Experience: Manufacturers benefit from partners who understand the language and compliance requirements of multiple international markets.
How Win & Winnow Helps Medical Device Manufacturers Scale Global Compliance
At Win & Winnow, we believe AI can be a powerful enabler of multilingual medical device communication, especially when paired with expert oversight and rigorous quality processes. Our life sciences translation and accessibility specialists help manufacturers navigate the growing complexity of MDR, IVDR, and emerging AI governance requirements while supporting faster global market access. We combine:
- Life sciences subject matter expertise
- Regulatory-focused translation workflows
- AI-enabled efficiency where appropriate
- Human linguistic validation
- Accessibility and usability best practices
- Comprehensive quality assurance processes
Whether you need support with Instructions for Use, product labeling, software localization, clinical documentation, regulatory submissions, or patient-facing materials, our goal is to help you reduce risk while improving operational efficiency.
The Future of Medical Device Translation Is Human-Guided AI
AI translation is rapidly becoming part of the medical device industry’s multilingual content strategy. The technology offers clear advantages in speed, scalability, and efficiency. However, compliance, patient safety, and regulatory readiness cannot be automated away.
Manufacturers remain responsible for ensuring that translated content is accurate, understandable, and suitable for its intended purpose. The organizations that will benefit most from AI are those that combine technological innovation with expert human oversight and robust quality controls.
If your organization is evaluating AI translation for medical devices, now is the time to establish a strategy that balances efficiency with compliance. Contact Win & Winnow to discuss how our life sciences translation and accessibility experts can help support your global growth objectives.
